Dr. Pritesh Kumar is the Managing Director of PhytoSciences GmbH, a Switzerland based consultancy comprising scientists & analysts across
the EU, Africa, Canada, India, and USA. Dr. Kumar has a diverse set of skills and experiences in the fields of structuring & commercializing
science assets, risk advisory, and investment due diligence. Dr. Kumar holds a Ph.D. in Pharmacology and Toxicology, with a focus in cannabinoid
(cannabis) pharmacology, from the University of Louisville, School of Medicine.
Dr. Kumar has provided consulting services to several U.S. state government officials as well as
international governments and policy officials on effective medical cannabis policies. He regularly advises
on laboratory facility design / optimization, cannabis testing equipment, analytical methodology
for cannabinoid analysis and separation, pharmacology of cannabis-based therapeutics and maintaining a QA
system to ensure compliance, including preparation of legislative documents to regulate a QA system with regard
to cannabis manufacturing and processing.
He has received numerous honors and awards including Best Oral Presentation from the
International Cannabinoid Research Society (ICRS) Conference in Vancouver and fellowships from Drug
Discovery and Target in Boston and Integrated Programs in Biomedical Sciences (IPIBS) as well as travel awards
from the National Institute on Drug Abuse for his presentations in Canada, Switzerland, Italy, USA, and Germany.